Investors react to Monday’s 13% decline in the market. The Federal Reserve introduces emergency lending programs. And shares of Regeneron Pharmaceuticals rise after the biotech company announces that it aims to have a potential drug for COVID 19 ready for trials this summer. Motley Fool analyst Jason Moser discusses those stories and share his investing approach during these volatile times.
Thanks to Molekule for supporting our channel. Get 10% off your first air purifier at http://www.molekule.com with code fool10.